NRAS MUTATION CODON 12, 13 & 61

Determination of NRAS status plays a role in determining the outcome of therapy in colorectal carcinoma. Absence of NRAS mutation within the tumor suggests that the patient may respond to therapy but other mutations such as EGFR, KRAS etc also play a role.

  • Test Type:
  • Pre-test Information:
    The paraffin block should have atleast 10% tumor tissue
  • Report Delivery:
    Sample by Tue 11 am; Report Mon
  • Components:
    0

Sample Report